The Lausanne University Hospital (CHUV) says it is proud to have been placed ninth in a global ranking of hospitals by the American magazine Newsweek.
This content was published on
2 minutes
CHUV/Keystone-SDA/ilj
The only other European institution to make it onto the list was Berlin’s Charité university hospital. Top of the list was the Mayo Clinic from the United States.
“… the world-class CHUV serves as the teaching hospital for the country’s French-speaking citizens”, wrote Newsweek.External link
“It was one of only two hospitals in Switzerland’s “Health Valley” (home to nearly 1,000 biotechnolgy and medical technology companies) chosen by the World Health Organization to conduct the all-important Ebola vaccine trials in October 2014,” it said in its explanation published this week.
More
More
Ebola vaccine trial to take place in Lausanne
This content was published on
The Swiss medical authorities have approved the application for a trial with an experimental Ebola vaccine at the Lausanne University Hospital (CHUV). It will be conducted on 120 volunteer participants.
The ranking was based on an assessment made by doctors, medical professionals and administrators across four continents, the New York-based magazine said.
Reaction
Professor Pierre-Francois Leyvraz, director general of the CHUV, said in a statement on ThursdayExternal link that he was extremely proud that the hospital was on this list, alongside such renowned institutions.
Also included were the Cleveland Clinic, the Johns Hopkins Hospital and the Massachusetts General Hospital in the US, as well as the Singapore General Hospital, as well as institutions in Japan, Canada and Israel.
He attributed the result to the instruction’s strategic vision and common efforts of the 11,000 people employed there and the management.
“The CHUV shows that a hospital, a cantonal public service, which is supported by a dynamic university, the University of Lausanne, can be at a level of international excellence in the care of patients, teaching and research,” he said.
Popular Stories
More
Swiss Abroad
The citizenship obstacle course facing spouses of Swiss Abroad
Automated driving on Swiss motorways is theoretically possible from March
This content was published on
It will be theoretically possible to hand over the steering wheel to technology but no such system has been submitted for official approval yet.
Heated atmosphere at Swiss rally against AfD politician Alice Weidel
This content was published on
Around 250 people demonstrated "against the right" and the German AfD politician Alice Weidel on Saturday afternoon in Einsiedeln.
This content was published on
The Ethos Foundation recommends that shareholders vote against all compensation-related items at the Annual General Meeting on March 7.
Top Swiss firms close to reaching gender quota in boards
This content was published on
The proportion of women on the boards of directors of the fifty largest listed companies in Switzerland currently stands at 28%.
Swiss committee wants to end government resignations during legislative term
This content was published on
Members of the Federal Council should no longer be able to leave office before the end of their term, according to a House of Representatives committee.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Researchers discover Swiss strain of hepatitis E
This content was published on
Researchers at Lausanne University Hospital (CHUV) have discovered a strain of the hepatitis E virus that is unique to Switzerland.
Electro-stimulation helps paraplegic patients walk again
This content was published on
Researchers in Switzerland have helped three paraplegic patients walk through electrical stimulation of the spinal cord using a wireless implant.
This content was published on
Geneva University Hospital (HUG) received approval from Swissmedic on Thursday to begin trials of a new type of Ebola vaccine received in October from the Canadian National Microbiology Laboratory. The trials will commence on November 10. After approval from the ethics committees of the Canton of Geneva and the World Health Organisation (WHO), HUG was…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.